Shaun D. Fouse, Ph.D.
Affiliations: | University of California, Los Angeles, Los Angeles, CA |
Google:
"Shaun Fouse"Mean distance: 16.98 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentor| Guoping Fan | grad student | 2008 | UCLA | |
| (Epigenetic gene regulation in mouse embryonic stem cells and the developing central nervous system.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bell RJ, Rube HT, Kreig A, et al. (2015) Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science (New York, N.Y.). 348: 1036-9 |
| van Thuijl HF, Mazor T, Johnson BE, et al. (2015) Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Acta Neuropathologica. 129: 597-607 |
| Fouse SD, Steino A, Butowski N, et al. (2015) Abstract B28: Dianhydrogalactitol inhibits the growth of glioblastoma multiforme stem and non-stem cultures, in vitro and in vivo Brain. 75 |
| Fouse SD, Steino A, Butowski N, et al. (2015) Abstract 2562: Dianhydrogalactitol inhibits the growth of glioma stem and non-stem cultures, including temozolomide-resistant cell lines, in vitro and in vivo Cancer Research. 75: 2562-2562 |
| Bell R, Rube HT, Kreig A, et al. (2015) GENO-07A MECHANISM OF MUTANT TERT PROMOTER ACTIVATION SHARED ACROSS CANCER TYPES Neuro-Oncology. 17: v92.3-v92 |
| Nagarajan RP, Zhang B, Bell RJ, et al. (2014) Recurrent epimutations activate gene body promoters in primary glioblastoma. Genome Research. 24: 761-74 |
| Fouse SD, Nakamura JL, James CD, et al. (2014) Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype. Neuro-Oncology. 16: 361-71 |
| Fouse S, Steino A, Butowski N, et al. (2014) ET-18 * VAL-083 IS A NOVEL N7 ALKYLATING AGENT THAT INHIBITS THE GROWTH OF GLIOMA STEM AND NON-STEM CULTURES, INCLUDING TEMOZOLOMIDE-RESISTANT LINES Neuro-Oncology. 16: v83-v83 |
| Sun MZ, Kim JM, Oh MC, et al. (2013) Naâº/Kâº-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro-Oncology. 15: 1518-31 |
| Fouse SD, Costello JF. (2013) Cancer Stem Cells Activate STAT3 the EZ Way. Cancer Cell. 23: 711-3 |